Clinical Trial Update: Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy of Adalimumab in patients with erosive osteoarthritis of the interphalangeal finger joints has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Osteoarthritis of the Interphalangeal Finger Joints

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Erosive Osteo-Arthritis | Phase 2 | Status: COMPLETED